Published in Biochem J on May 15, 1999
2,4,6,7-Tetra-methyl-3-phenyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2008) 2.91
5-Bromo-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 2.23
5-Chloro-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.91
5-Bromo-3-ethyl-sulfinyl-2-(4-fluoro-phenyl)-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2010) 1.79
2-(4-Bromo-phen-yl)-5-fluoro-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.68
5-Fluoro-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.67
5-Fluoro-2-(4-iodo-phen-yl)-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.56
5-Chloro-3-ethyl-sulfinyl-2-(4-fluoro-phen-yl)-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2010) 1.55
Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. Nat Chem Biol (2011) 1.54
5-Bromo-2,7-dimethyl-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.53
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol (2009) 1.44
5-Bromo-2-phenyl-3-phenyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.38
Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc Natl Acad Sci U S A (2002) 1.30
Crystal structure of 2,5-dimethyl-3-(3-methyl-phenyl-sulfon-yl)-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 1.27
Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J (2000) 1.23
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF. Alzheimers Dement (2013) 1.22
5-Chloro-2-phenyl-3-phenyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.20
2-(5-Fluoro-3-methyl-sulfanyl-1-benzofuran-2-yl)acetic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 1.11
2-(5-Isopropyl-3-methyl-sulfanyl-1-benzofuran-2-yl)acetic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 1.10
Crystal structure of 5-chloro-2,7-dimethyl-3-[(4-methyl-phenyl)-sulfon-yl]-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 1.08
5-Bromo-2-(4-fluoro-phen-yl)-7-methyl-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 1.02
2-(4-Bromo-phen-yl)-5,6-methyl-enedi-oxy-3-phenyl-sulfinyl-1-benzofuran benzene solvate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.00
Ethyl 2-(5-fluoro-3-methyl-sulfinyl-1-benzofuran-2-yl)acetate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.00
2-(4-Fluoro-phen-yl)-5,6-methyl-enedi-oxy-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2010) 0.99
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. Biochem J (1999) 0.97
Methyl 2-(5-fluoro-3-methyl-sulfinyl-1-benzofuran-2-yl)acetate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.91
Isopropyl 2-[5-(4-hydroxy-phen-yl)-3-methyl-sulfanyl-1-benzofuran-2-yl]acetate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.90
Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. Cell Mol Neurobiol (2002) 0.86
3-(1,3-Benzodioxol-5-yl)-3H-benzo[f]isobenzofuran-1-one. Acta Crystallogr Sect E Struct Rep Online (2010) 0.85
2-(3-Ethyl-sulfanyl-5-fluoro-1-benzofuran-2-yl)acetic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 0.85
5-(4-Bromo-phen-yl)-2-methyl-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 0.85
Anti-amyloidogenic properties of some phenolic compounds. Biomolecules (2015) 0.78
Quantitative structure-activity relationship analysis of β-amyloid aggregation inhibitors. J Comput Aided Mol Des (2010) 0.76
Structural differences of amyloid-β fibrils revealed by antibodies from phage display. BMC Biotechnol (2015) 0.76
Carnosine's effect on amyloid fibril formation and induced cytotoxicity of lysozyme. PLoS One (2013) 0.76
3-(2-Meth-oxy-naphthalen-1-yl)-2-benzofuran-1(3H)-one. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
5-Chloro-3-(4-fluoro-phenyl-sulfon-yl)-2,7-dimethyl-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
Crystal structure of 2-ethyl-3-(4-fluoro-phenyl-sulfin-yl)-5,7-dimethyl-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
Crystal structure of 5-chloro-3-cyclo-hexyl-sulfinyl-2,4,6-trimethyl-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
2-(4-Chloro-phen-yl)-5-fluoro-3-methyl-sulfinyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
2-(5-Methyl-3-methyl-sulfinyl-1-benzofuran-2-yl)acetic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
5-Fluoro-3-methyl-sulfinyl-2-phenyl-1-benzofuran. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
2-(3-Ethyl-sulfanyl-5-phenyl-1-benzofuran-2-yl)acetic acid. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Crystal structure of 5-chloro-3-(4-fluoro-phenyl-sulfin-yl)-2,4,6-trimethyl-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
Neuroprotective and antioxidant effects of novel benzofuran-2-carboxamide derivatives. Biomol Ther (Seoul) (2015) 0.75
Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors. Bioorg Med Chem Lett (2013) 0.75
Crystal structure of 2-ethyl-3-(4-fluoro-phenyl-sulfon-yl)-5,7-dimethyl-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
Isopropyl 2-(5-fluoro-3-methyl-sulfinyl-1-benzofuran-2-yl)acetate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Isoamyl 2-(5-bromo-3-methyl-sulfin-yl-1-benzofuran-2--yl)acetate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Crystal structure of 5-chloro-2,4,6-trimethyl-3-(4-methyl-phenyl-sulfin-yl)-1-benzo-furan. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
Methyl 2-[5-(4-hydroxy-phen-yl)-3-methyl-sulfanyl-1-benzofuran-2-yl]acetate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell (1993) 10.15
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods (1989) 9.42
Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci (1993) 7.92
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science (1990) 6.03
Hydrogen peroxide mediates amyloid beta protein toxicity. Cell (1994) 5.19
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17
Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science (1989) 3.47
In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res (1991) 3.45
Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem (1996) 3.10
Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med (1995) 2.27
The toxicity in vitro of beta-amyloid protein. Biochem J (1995) 2.17
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun (1996) 1.73
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry (1996) 1.55
Selective inhibition of Abeta fibril formation. J Biol Chem (1996) 1.53
Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem (1997) 1.46
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration (1995) 1.45
Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem (1997) 1.43
Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem (1996) 1.42
A beta deposition inhibitor screen using synthetic amyloid. Nat Biotechnol (1997) 1.37
Hemin and related porphyrins inhibit beta-amyloid aggregation. FEBS Lett (1997) 1.34
beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol Aging (1993) 1.31
Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion. Neurosci Lett (1995) 1.28
Brain amyloid--a physicochemical perspective. Brain Pathol (1996) 1.27
beta-Cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide. FEBS Lett (1994) 1.11
The role of protein phosphorylation in beta amyloid toxicity. Brain Res (1997) 1.03
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry (2004) 3.90
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem (1999) 2.86
Healing of arterial prostheses in man: its incompleteness. Ann Surg (1972) 1.97
Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Nature (1991) 1.90
A comparison of the folding kinetics and thermodynamics of two homologous fibronectin type III modules. J Mol Biol (1997) 1.89
Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res (2009) 1.86
The 5-HT(1A) receptor knockout mouse and anxiety. Behav Pharmacol (2001) 1.85
Gene expression profiling in the adult Down syndrome brain. Genomics (2007) 1.73
Hippocampal volume and everyday memory in children of very low birth weight. Pediatr Res (2000) 1.69
Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus. Mol Microbiol (2001) 1.65
Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem (1997) 1.51
Rapid refolding of a proline-rich all-beta-sheet fibronectin type III module. Proc Natl Acad Sci U S A (1996) 1.49
Destabilization of the complete protein secondary structure on binding to the chaperone GroEL. Nature (1994) 1.49
Mitral valve disease and open heart surgery in osteogenesis imperfecta tarda. Br Heart J (1973) 1.46
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration (1995) 1.45
Future directions in the development of arterial prostheses for small and medium caliber arteries. Surg Clin North Am (1974) 1.45
Laterality of expression in portraiture: putting your best cheek forward. Proc Biol Sci (1999) 1.45
Exfoliative cytology in the diagnosis of breast disease. Br J Surg (1995) 1.38
Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem (2000) 1.35
Unilateral axillary bilateral femoral bifurcation graft: a procedure for the poor risk patient with aortoiliac disease. Surgery (1966) 1.34
Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol (1997) 1.33
An external velour surface for porous arterial prostheses. Surgery (1971) 1.32
Building proteins with fibronectin type III modules. Structure (1994) 1.29
Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res (2011) 1.27
The preclotting of porous arterial prostheses. Ann Surg (1978) 1.25
Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry (2008) 1.24
Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J (2000) 1.23
Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol (2000) 1.21
An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med (2000) 1.21
Interspecies healing of porous arterial prostheses: observations, 1960 to 1974. Arch Surg (1974) 1.20
Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry (2007) 1.18
Technique for correction of mitral insufficiency by leaflet advancement. J Thorac Cardiovasc Surg (1966) 1.17
A disturbed sense of self in the psychosis prodrome: linking phenomenology and neurobiology. Neurosci Biobehav Rev (2009) 1.16
High affinity binding of the Entamoeba histolytica lectin to polyvalent N-acetylgalactosaminides. J Biol Chem (1995) 1.15
Presence of endothelium in an axillary-femoral graft of knitted Dacron with an external velour surface. Ann Surg (1975) 1.15
A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry (2007) 1.12
Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone. Antimicrob Agents Chemother (1981) 1.09
Differential localization of voltage-dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction. J Neurosci (1997) 1.09
Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res (2010) 1.08
The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord (1999) 1.08
Payment or altruism? The motivation behind gamete donation. Hum Reprod (1997) 1.05
Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res (2006) 1.05
Bilateral superficial radial artery at the wrist associated with a radial origin of a unilateral median artery. J Anat (1996) 1.03
Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol (2001) 1.01
Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. Acta Psychiatr Scand (2014) 1.01
Structures and solution properties of two novel periplasmic sensor domains with c-type heme from chemotaxis proteins of Geobacter sulfurreducens: implications for signal transduction. J Mol Biol (2008) 0.99
Endoscopic transthoracic sympathectomy: experience in the south west of England. Eur J Vasc Surg (1992) 0.98
Axillofemoral bypass: a critical reappraisal of its role in the management of aortoiliac occlusive disease. Am J Surg (1979) 0.97
Attachment factors amont enterotoxigenic Escherichia coli from patients with acute diarrhea from diverse geographic areas. Infect Immun (1981) 0.97
Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust N Z J Psychiatry (2000) 0.97
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. Biochem J (1999) 0.97
Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase. J Med Chem (1994) 0.96
Comparison of noncrimped, externally supported (EXS) and crimped, nonsupported Dacron prostheses for axillofemoral and above-knee femoropopliteal bypass. Surgery (1982) 0.94
Effects of low intensity radiofrequency electromagnetic fields on electrical activity in rat hippocampal slices. Brain Res (2001) 0.92
Experimental coronary artery surgery. Long-term follow-up, bypass venous autografts, longitudinal arteriotomies, and end-to-end anastomoses. J Thorac Cardiovasc Surg (1968) 0.92
Successful interposition synthetic graft between aorta and right coronary artery. Angiographic follow-up to sixteen months. J Thorac Cardiovasc Surg (1976) 0.92
Sewing ring healing of cardiac valve prostheses. Surgery (1967) 0.91
Prosthetic heart valve replacement. Ann N Y Acad Sci (1968) 0.91
Characterizing anterior cingulate activation in chronic schizophrenia: a group and single-subject fMRI study. Acta Psychiatr Scand (2007) 0.90
Orthostatic intolerance and motion sickness after parabolic flight. J Appl Physiol (1985) (2001) 0.89
Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain (2002) 0.89
The incidence and significance of testicular microlithiasis in a subfertile population. Br J Radiol (2000) 0.89
In vivo evidence for early neurodevelopmental anomaly of the anterior cingulate cortex in bipolar disorder. Acta Psychiatr Scand (2007) 0.89
Prevalence of psychiatric diagnoses in preterm and full-term children, adolescents and young adults: a meta-analysis. Psychol Med (2011) 0.88
Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology (2001) 0.88
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des (2012) 0.87
Reduced volume of parietal and frontal association areas in patients with schizophrenia characterized by passivity delusions. Psychol Med (2005) 0.87
Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients. Schizophr Res (2009) 0.87
Endarterectomy and other surgical injuries to cardiovascular walls. Pac Med Surg (1968) 0.86
Analysis of fibril elongation using surface plasmon resonance biosensors. Methods Enzymol (1999) 0.86
Synthesis of novel modified dipeptide inhibitors of human collagenase: beta-mercapto carboxylic acid derivatives. J Med Chem (1993) 0.86
Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteria. Eur J Clin Microbiol (1983) 0.85
Alzheimer's disease: correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome. J Neurochem (1999) 0.85
Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis. Psychol Med (2013) 0.85
Protein secondary structure determination by NMR. Application with recombinant human cyclophilin. FEBS Lett (1991) 0.85
Effect of acute exposure to hypergravity (GX vs. GZ) on dynamic cerebral autoregulation. J Appl Physiol (1985) (2001) 0.85
Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells. Biochem J (2000) 0.85
Role of leukotriene B4 in the pathogenesis of Klebsiella pneumoniae-induced bovine mastitis. Am J Vet Res (1989) 0.84
Pigmented squamous cell carcinoma. J Cutan Pathol (2000) 0.84
Autogenous pericardium as a graft for the ventricular septum. Technic and evaluation in 14 cases. Am Surg (1966) 0.83
Influence of amount of exposed fabric on thrombotic complications of aortic ball valves in the calf. Am J Surg (1968) 0.83
A simple in vivo model of collagen degradation using collagen-gelled cotton buds: the effects of collagenase inhibitors and other agents. Inflamm Res (1995) 0.83
Comparison of ovarian response in right and left ovaries in IVF patients. Hum Reprod (2001) 0.83
Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies. Brain (1997) 0.82
Conformational polymorphism of cyclosporin A. Structure (1994) 0.82
Quantitative magnetic resonance characterization of mesial temporal sclerosis in childhood. Neurology (2001) 0.81
A very thin, porous, knitted arterial prosthesis: experimental data and early clinical assessment. Surgery (1969) 0.81
Reciprocal modulation of glutamate and GABA release may underlie the anticonvulsant effect of phenytoin. Neuroscience (2000) 0.81
Salbutamol: clinical application as pressure-packed aerosol. Postgrad Med J (1971) 0.81
Diffusion barrier properties of the perineurium: an in vivo ionic lanthanum tracer study. Anat Embryol (Berl) (1989) 0.81
Selective bilateral hippocampal volume loss in chronic schizophrenia. Biol Psychiatry (2001) 0.81
Endometrial integrin expression in women undergoing IVF and ICSI: a comparison of the two groups and fertile controls. Hum Reprod (2003) 0.80
Cowden's syndrome, Lhermitte-Duclos disease, and sclerotic fibroma. Am J Dermatopathol (1998) 0.80
Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. Transl Psychiatry (2013) 0.80
Effect of calving supervision upon the calving performance of Hereford heifers. Aust Vet J (1982) 0.80
In vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitor. Ann Rheum Dis (1995) 0.80
Dermatofibrosarcoma protuberans of the oral cavity. J Am Acad Dermatol (1999) 0.79